dc.contributor.author | Khadeir, R | en_US |
dc.contributor.author | Szyszko, T | en_US |
dc.contributor.author | Szlosarek, PW | en_US |
dc.date.accessioned | 2018-06-04T15:02:55Z | |
dc.date.available | 2017-10-24 | en_US |
dc.date.issued | 2017-11-14 | en_US |
dc.date.submitted | 2018-03-21T22:09:31.445Z | |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/39244 | |
dc.format.extent | 96468 - 96469 | en_US |
dc.language | eng | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Oncotarget | en_US |
dc.rights | This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. | |
dc.subject | ASS1 | en_US |
dc.subject | arginine | en_US |
dc.subject | arginine depletion | en_US |
dc.subject | cancer | en_US |
dc.subject | resistance | en_US |
dc.title | Optimizing arginine deprivation for hard-to-treat cancers. | en_US |
dc.type | Article | |
dc.rights.holder | (c) Khadeir et al. | |
dc.identifier.doi | 10.18632/oncotarget.22099 | en_US |
pubs.author-url | https://www.ncbi.nlm.nih.gov/pubmed/29228540 | en_US |
pubs.issue | 57 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published online | en_US |
pubs.volume | 8 | en_US |
dcterms.dateAccepted | 2017-10-24 | en_US |